The IDPOC conference is held in conjunction with the World Congress of Dermatology 2015, June 8-13, in Vancouver, Canada.
Ballerup, Denmark, 11 June 2015 – During the three days of the IDPOC (June 11-13), more than 150 dermatology patient leaders from around the globe meet to exchange knowledge and participate in workshops on topics such as fundraising, advocacy, social media and health economics. The patient leaders represent patient associations in the areas of psoriasis, skin cancer, vitiligo, acne, burn survivors, eczema and various other skin diseases impacting on the quality of life for millions of people around the world.
“Many patients with skin diseases feel stigmatised. Skin diseases are often chronic and patients may have to live with debilitating itch, pain and visible skin disorders for a life-time, which in many cases leads to social stigmatisation and exclusion. By bringing patient leaders together, we hope to build a strong network and support raising awareness and strengthen the voice of patients to help the many patients around the world who are daily suffering from stigma and social exclusion due to their skin,” said Christine Janus, host of the first IDPOC and Director of the Canadian Skin Patient Alliance.
LEO Pharma is the main sponsor of IDPOC, and in her opening speech this morning, LEO Pharma CEO & President Gitte Aabo thanked patient leaders for their invaluable contribution towards advancing care for people with skin diseases.
“Patient leaders are the true heroes of dermatology. Without their tireless commitment we would not be where we are today. But we still have a lot to achieve. Patient associations, industries, researchers and public health authorities share a common objective of helping people with skin diseases. Only by working together and breaking down silos, can we make a real-life difference to patients,” said Gitte Aabo.
“I’m proud that LEO Pharma was invited to play an instrumental role in turning the vision of this historic conference into reality. I hope it marks the start of a new era for dermatology patients worldwide.”
Increased focus on patients
LEO Pharma recently committed to a stronger focus on patients with the launch of its corporate strategy entitled ‘Helping SARAH – LEO towards 2020’.
“’Helping SARAH’ gives name to the individual patients we serve and guides our entire organisation around the patient. Patients like ‘SARAH’ need better care as living with a serious skin disease has a profound impact on everyday life. At LEO Pharma, we will continue in our efforts to meet the needs of individual patients with skin diseases – even when there is no immediate commercial gain,” said Gitte Aabo.
LEO Pharma is 100% owned by the LEO Foundation, which means that the company is first and foremost accountable to patients.
About LEO Pharma
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 4,800 people worldwide.
Subscribe to our YouTube channel: www.youtube.com/leopharmaglobal
Follow us on Twitter: www.twitter.com/leohealthyskin
Visit us at LinkedIn: www.linkedin.com/company/leo-pharma